Semaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...

Until recently, several glucagon-like peptide-1 (GLP-1) injections were in shortage. During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

Anodyne’s HeroPatch™ demonstrates ability to deliver therapeutic doses of a once-weekly GLP-1 without injections in preclinical trials, pointing to enhanced patient adherence and cost savings ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial ... non-motor scores, quality-of-life assessments, and changes in levodopa-equivalent daily doses ...

The GLP-1 receptor agonist drug ... have come up with a new drug delivery system that they claim could cut the dosing schedule for GLP-1 drugs to just a ... the equivalent of four months ...

Novo Nordisk has a GLP-1 pill, Rybelsus, but it contains the GLP-1 peptide, so it must be taken in large doses and is not as effective as the injectables because most of it is digested.

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 ...